← back to search

Yiqiang Wang

Xiamen University · CN
Area of research
Radiology, Nuclear Medicine and Imaging · Public Health, Environmental and Occupational Health
Research interest
Research focused on Antibody and Proteome, with related work in Aryl hydrocarbon receptor, Monoclonal antibody, Pharmacology. Notable publications include 'Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists' and 'An array of 60,000 antibodies for proteome-scale antibody generation and target discovery'.
h-index
citations
98
works
3
NIH funding
primary concept
email

Recent publications

Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists
Science Advances 2020cited by 55position: middledoi
An array of 60,000 antibodies for proteome-scale antibody generation and target discovery
Science Advances 2020cited by 37position: middledoi
An Array of 60,000 Antibodies for Proteome-Scale Antibody Generation and Target Discovery
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 6position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Beena Thomas · Emory University1 papers (2020–2020)Alykhan Premji · APLA Health1 papers (2020–2020) · 1 papers (2020–2020)Carolyn A. Haller · Beth Israel Deaconess Medical Center1 papers (2020–2020)Swati S. Bhasin · Emory University1 papers (2020–2020)Elliot L. Chaikof · Broad Institute1 papers (2020–2020)Manoj Bhasin · Emory University1 papers (2020–2020)Jiaxuan Chen · Beth Israel Deaconess Medical Center1 papers (2020–2020)Julian Kwan · Boston University1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2020–2020)Revanth Kosaraju · California Institute for Regenerative Medicine1 papers (2020–2020)Dayoung Park · University of California, Davis1 papers (2020–2020)Roberto C. De La Rosa · Dartmouth College1 papers (2020–2020) · 1 papers (2020–2020)Alan C. Moss · Action Against Medical Accidents1 papers (2020–2020)Andrew Emili · Oregon Health & Science University1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2020–2020)Liying Liu · Zhejiang Chinese Medical University1 papers (2020–2020)